ANDR:VIEANDRITZ AG Analysis
Data as of 2026-03-11 - not real-time
$0.00
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The stock is trading at the same level as both its short‑term and medium‑term moving averages, creating a tight support and resistance zone. Technical momentum indicators sit near the neutral midpoint, while the MACD has turned bearish, suggesting limited upside. Volume has been on a downward trajectory, reinforcing the bearish bias. Market sentiment is extremely greedy according to the fear‑and‑greed index, yet the price remains constrained by thin trading. Beta is notably high, indicating the share moves more sharply than the broader market. Recent price action shows virtually no monthly volatility, reflecting a stagnant market environment.
Fundamentally, the company reports negative operating margins and a loss‑making bottom line, with cash flow turning sharply negative. Debt dwarfs cash reserves, leaving the balance sheet heavily leveraged. Gross margin remains modest, but the inability to convert sales into profit drives a severe historical drawdown. The price‑to‑book ratio is negative, and earnings multiples are undefined, underscoring valuation challenges. With no dividend and a tiny market capitalization, liquidity is extremely limited, amplifying execution risk. Overall, the combination of distressed fundamentals and adverse technical signals points to a high‑risk profile.
Fundamentally, the company reports negative operating margins and a loss‑making bottom line, with cash flow turning sharply negative. Debt dwarfs cash reserves, leaving the balance sheet heavily leveraged. Gross margin remains modest, but the inability to convert sales into profit drives a severe historical drawdown. The price‑to‑book ratio is negative, and earnings multiples are undefined, underscoring valuation challenges. With no dividend and a tiny market capitalization, liquidity is extremely limited, amplifying execution risk. Overall, the combination of distressed fundamentals and adverse technical signals points to a high‑risk profile.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- bearish MACD and neutral RSI
- decreasing volume and thin liquidity
- severe negative cash flow and high debt
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- ongoing operating losses
- lack of growth prospects
- high beta and market volatility
Long Term
> 3 yearsCautious
Model confidence: 5/10
Key Factors
- potential for restructuring
- extreme debt load
- uncertain market adoption
Key Metrics & Analysis
Financial Health
Revenue Growth-36.80%
Profit Margin-14.69%
ROA-20.03%
P/B Ratio-0.0
Op. Cash Flow$-226187
Free Cash Flow$-277572
Industry P/E36.8
Technical Analysis
TrendBearish
RSI51.8
Support$0.00
Resistance$0.00
MA 20$0.00
MA 50$0.00
MA 200$0.00
MACDBearish
VolumeDecreasing
Fear & Greed Index76.45
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.41
0Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.